Camp Lejeune cancer lawsuit

Part Two Of February Camp Lejeune Justice Act Recap

Filing deadlines, types of cancer and other key takeaways from recent Camp Lejeune water contamination news

Sunday, February 25, 2024 - With the deadline for submitting a Camp Lejeune Justice Act claim approaching in August 2024, eligible individuals must take timely action. Notably, the receipt of VA benefits should not deter claimants from seeking compensation under the Act. Understanding the implications of the deadline and the necessary steps for claim submission is essential for maximizing the chances of receiving rightful compensation and addressing the health consequences of exposure to contaminated water. If one's claim is rejected or if the Navy fails to address one's claims for six months, a claimant may file a Camp Lejeune water lawsuit in the Eastern District of North Carolina where Camp Lejeune is located. Unfortunately perhaps, and contrary to expectations, Camp Lejeune water contamination lawsuits will be adjudicated by judges rather than juries. This shift in the legal process underscores the complexity and unique nature of these cases, which require specialized expertise and an understanding of the intricate legal and scientific dimensions involved. Not only that, to a large extent trials by a judge and not a jury is expected to greatly speed up the process by which claims may be paid.

Many types of cancer may now be associated with long-term exposure to Camp Lejeune water contamination. Recent findings from a federal study have brought to light alarming revelations regarding elevated cancer risks associated with exposure to contaminated water at Camp Lejeune. The inclusion of eight additional types of cancer in the study underscores the severity of health consequences faced by individuals exposed to the toxic chemicals present in the water supply. The release of a newly expanded list of diseases linked to Camp Lejeune water contamination by the CDC has significant implications for affected individuals and ongoing legal proceedings. The inclusion of diseases such as male breast cancer and lung cancer alongside existing conditions underscores the multifaceted health risks associated with exposure to contaminated water. Particular attention must be given to understanding and addressing the diverse health challenges faced by veterans, families, and civilian personnel affected by the Camp Lejeune water crisis. These findings emphasize the urgent need for comprehensive remedial measures and the swift dispensation of justice to compensate those who have suffered and their families.

Plaintiffs' attorneys will now be required to put in more hours and for less money. The federal government has added yet another barrier to the Camp Lejeune Justice Act's provision of lump-sum financial compensation for plaintiffs suffering from neurological diseases or cancer. US Marines, civilian employees, and anyone else who has spent more than 30 days at Camp Lejeune may launch a lawsuit in the Eastern District of North Carolina if their administrative claim is rejected or disregarded for six months. It is no longer a given for plaintiffs to assert that their illness was brought on by their stay at the base. The burden of proof for plaintiffs is to demonstrate a causal connection between consuming the contaminated water and contracting the relevant illness.

Information provided by CampLejeuneJusticeActClaim.com, a website devoted to providing news about Camp Lejeune Justice Act Claim, including a free no-cost, no-obligation Camp Lejeune Justice Act Claim.

More Recent Camp Lejeune Water Lawsuit News:

View all Camp Lejeune Justice Act Claim News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer After Spending 30 Days or More at Camp Lejeune between 1953 and 1988

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.